News

ExCulture secures funding from the Dutch Industrial Biotech Seed Fund (managed by Capricorn Partners) and TTT Medtech

Leiden, 12th July 2024 – ExCulture B.V., a biotechnology startup focused on the development of an animal-free heparin substitute via fermentation, is proud to share that it has closed its latest funding round with Capricorn Partners and T
Aisling Foley (left) and Ilaria Poledri (right)

Impact the world with your mission-driven business initiative and elevate your career in life sciences: join the BioBusiness Masterclass!

As a biotech entrepreneur, you are at the forefront of developing next-generation diagnostics, treatments, sustainable foods, and a range of other biobased products.
Impact the world with your mission-driven business initiative and elevate your career in life sciences: join the BioBusiness Masterclass!

FETCH wins Venture Challenge Spring 2024!

The winner of the Venture Challenge was announced today at the Dutch Biotech Event.
FETCH wins Venture Challenge Spring 2024!

UPyTher attracts seed financing to advance the development of its lead product UPT-211 for treatment of peritoneal cancer of colorectal cancer origin.

Eindhoven, The Netherlands, June 10th, 2024, UPyTher announces seed financing from Essential Investments, Brabant Development Agency (BOM) and TTT Medtech.
UPyTher attracts seed financing to advance the development of its lead product UPT-211 for treatment of peritoneal cancer of colorectal cancer origin.

The consortium led by ParaMedir awarded with more than €1.8 Million in European Funding by Just Transition Fund (JTF) to advance Healthcare through innovative biomonitoring solutions.

Groningen, 14th June, 2024 – ParaMedir proudly announces the award of approximately €1.8 million in European funding from the Just Transition Fund (JTF).
Logo ParaMedir

Pitch to impress at this year's HealthTech Investor Summit!

Europe’s healthtech sector is growing, and we’re all facing similar challenges. At the HealthTech Investor Summit, we bring together investors, innovators, mentors, and experts to help companies form the connections they need to flourish.
Apply now for the HealthTech Investor Summit

Must watch: Documentary 'Acerta's Pharmaceutical Journey of Discovery'

About fifteen years ago, a special molecule was born in Oss at the current Pivot Park.
Screenshot of the documentary, with the title on screen

These are the Venture Challenge Spring 2024 teams!

Six teams have started the Venture Challenge Spring 2024! Between 6 May and 28 June these starting lifesciences entrepreneurs will learn everything there is to know about building and pitching a businessplan.
sfeerimpressie

ExoVectory awarded Eurostars grant for ex vivo engineering of therapeutic T-cells

ExoVectory in collaboration with UMC Utrecht, Utrecht University and EVerZom is awarded with the Eurostars grant - total value project €1,5Mio - for their innovative approach to developing an ex vivo engineered T-cell
eurostars beeldje exovectory

Venture Challenge Spring 2024 has kicked-off

The Venture Challenge Spring 2024 Kicked-off this week at Pivot Park. Six teams eager to bring their inventions to market joined us in the first 3-day bootcamp.
Venture Challenge Spring 2024